Member access

4-Traders Homepage  >  Shares  >  Swiss Exchange  >  Roche Holding Ltd.    ROG   CH0012032048

ROCHE HOLDING LTD. (ROG)

181
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Swiss Exchange
09/24/2014 09/25/2014 09/26/2014 09/29/2014 09/30/2014 Date
283.8(c) 282.5(c) 280.9(c) 280.7(c) 283.1(c) Last
1 179 077 1 375 789 1 054 083 1 083 284 1 274 229 Volume
+0.57% -0.46% -0.57% -0.07% +0.86% Change
More quotes
Company
Roche Holding AG is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics.As a large biotech company, Roche has truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience.It is also a leader in in-vitro... 
Sector
Pharmaceuticals
Calendar
09/29 | 04:00amPresentation
Surperformance© rating of Roche Holding Ltd.
Trading Rating : Investor Rating :
More about the company
Chart ROCHE HOLDING LTD.
Duration : Period :
Roche Holding Ltd. Technical Analysis Chart | ROG | CH0012032048 | 4-Traders
Full-screen chart
Financials ( CHF)
Sales 2014 47 260 M
EBIT 2014 17 454 M
Net income 2014 12 114 M
Debt 2014 5 095 M
Yield 2014 2,90%
Sales 2015 49 204 M
EBIT 2015 18 548 M
Net income 2015 13 065 M
Finance 2015 697 M
Yield 2015 3,11%
PER 2014 20,03
PER 2015 18,37
EV / Sales 2014 5,25x
EV / Sales 2015 4,93x
Capitalization 243 216 M
More Financials
Latest news on ROCHE HOLDING LTD.
2d ago ROCHE : Genentech :’s Investigational Combination of Cobimetinib Plus Zelb..
3d ago ROCHE : Genentech :’s Perjeta Regimen Extended the Lives of People With an..
7d ago Adaptimmune raises $104 million to develop immune-system cancer drugs
09/17 For Roche CEO, celebrating failure is key to success
09/16 Roche's $8 billion InterMune buy not a signal for more big deals
09/08 Cost a focus as GSK takes lead in new wave of biotech lung drugs
09/04 Roche rules out mega deals, open to smaller ones - paper
09/04 Ex-Genentech boss Levinson resigns from Roche's board
09/03 Google's Calico, AbbVie forge deal against diseases of aging
08/27 InterMune drug may offer big upside to Roche if aimed at liver
08/25DJMARKET SNAPSHOT : S&P 500 Jumps To Record Close Just Below 2,000
08/25 S&P 500 sets record high but fails to hold 2,000 mark
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF